Service oriented centered e-health solution for monitoring and preventing chronic diseases

The modern and continuously changing lifestyles in almost all parts of the world resulted in an increase in the incidence of chronic diseases (CDs). To reduce risks associated with chronic diseases, health professionals are studying various clinical solutions. As a result of recent advances in sensing technology, wireless communications, and distributed communication, the monitoring of patients\u27 health condition and the elaboration of prevention plans are considered the most promising solutions for the treatment of chronic diseases. In this paper, we propose a novel framework for monitoring chronic diseases and tracking their vital signs. The framework relies on the service orientation concepts and standards to integrate various subsystems. Monitoring of subjects\u27 health condition, using various sensors and wireless devices, aims to proactively detect any risk of chronic diseases. The system will allow generating and customizing preventive plans dynamically according to the subject\u27s health profile and context while considering many impelling parameters. As a proof of concept of our monitoring and tracking schemes, we have considered a case study for which we have collected and analyzed preliminary data

Acute toxicity of essential oils of two Moroccan endemic species: Thymus broussonetii and Thymus leptobotrys

Abstract Thymus species essential oils are widely used in aromatherapy to treat several ailments. However, there is no report on their safety. In this study, we propose to investigate the acute toxicity of T. leptobotrys and T. broussonetii essential oils. These two species were selected on the basis of their frequency of medicinal use and commercial importance. Chemical analysis of these two species essential oil revealed that thymol, borneol, carvacrol and p-cymene were the main chemical constituents in T. broussonetii, whereas the essential oil of T. leptobotrys contains carvacrol (98 %) as the major component. In the acute toxicity assay, the animals showed no stereotypical symptoms associated with toxicity such as convulsion, ataxy, diarrhoea or increased diuresis. The calculated median lethal dose (LD 50 ) was estimated at 4.47 g/kg for T. broussonetii and 2.66 g/kg for T. leptobotrys

Anti-tumor properties of blackseed (Nigella sativa L.) extracts

Abstract The objective of the present study was to evaluate the in vitro and in vivo anti-cancer effect of Nigella sativa L. seed extracts. The essential oil (IC 50 = 0.6%, v/v) and ethyl acetate (IC 50 = 0.75%) extracts were more cytotoxic against the P815 cell line than the butanol extract (IC 50 = 2%). Similar results were obtained with the Vero cell line. Although all extracts had a comparable cytotoxic effect against the ICO1 cell line, with IC 50 values ranging from 0.2 to 0.26% (v/v), tests on the BSR cell line revealed a high cytotoxic effect of the ethyl acetate extract (IC 50 = 0.2%) compared to the essential oil (IC 50 = 1.2%). These data show that the cytotoxicity of each extract depends on the tumor cell type. In vivo, using the DBA2/P815 (H 2 d ) mouse model, our results clearly showed that the injection of the essential oil into the tumor site significantly inhibited solid tumor development. Indeed, on the 30th day of treatment, the tumor volume of the control animals was 2.5 ± 0.6 cm 3 , whereas the tumor volumes of the essential oil-treated animals were 0.22 ± 0.1 and 0.16 ± 0.1 cm 3 when the animals were injected with 30 µL (28.5 mg)/mouse and 50 µL (47.5 mg)/mouse per 48 h (six times), respectively. Interestingly, the administration of the essential oil into the tumor site inhibited the incidence of liver metastasis development and improved mouse survival. Correspondence A. Zya

Anti-tumor properties of black seed (Nigella Sativa)extract

Abstract The objective of the present study was to evaluate the in vitro and in vivo anti-cancer effect of Nigella sativa L. seed extracts. The essential oil (IC 50 = 0.6%, v/v) and ethyl acetate (IC 50 = 0.75%) extracts were more cytotoxic against the P815 cell line than the butanol extract (IC 50 = 2%). Similar results were obtained with the Vero cell line. Although all extracts had a comparable cytotoxic effect against the ICO1 cell line, with IC 50 values ranging from 0.2 to 0.26% (v/v), tests on the BSR cell line revealed a high cytotoxic effect of the ethyl acetate extract (IC 50 = 0.2%) compared to the essential oil (IC 50 = 1.2%). These data show that the cytotoxicity of each extract depends on the tumor cell type. In vivo, using the DBA2/P815 (H 2 d ) mouse model, our results clearly showed that the injection of the essential oil into the tumor site significantly inhibited solid tumor development. Indeed, on the 30th day of treatment, the tumor volume of the control animals was 2.5 ± 0.6 cm 3 , whereas the tumor volumes of the essential oil-treated animals were 0.22 ± 0.1 and 0.16 ± 0.1 cm 3 when the animals were injected with 30 µL (28.5 mg)/mouse and 50 µL (47.5 mg)/mouse per 48 h (six times), respectively. Interestingly, the administration of the essential oil into the tumor site inhibited the incidence of liver metastasis development and improved mouse survival